These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Docosahexaenoic acid signaling modulates cell survival in experimental ischemic stroke penumbra and initiates long-term repair in young and aged rats. Eady TN; Belayev L; Khoutorova L; Atkins KD; Zhang C; Bazan NG PLoS One; 2012; 7(10):e46151. PubMed ID: 23118851 [TBL] [Abstract][Full Text] [Related]
11. Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection. Belayev L; Marcheselli VL; Khoutorova L; Rodriguez de Turco EB; Busto R; Ginsberg MD; Bazan NG Stroke; 2005 Jan; 36(1):118-23. PubMed ID: 15569878 [TBL] [Abstract][Full Text] [Related]
12. MRZ 2/579, a novel uncompetitive N-methyl-D-aspartate antagonist, reduces infarct volume and brain swelling and improves neurological deficit after focal cerebral ischemia in rats. Liu Y; Belayev L; Zhao W; Busto R; Ginsberg MD Brain Res; 2000 Apr; 862(1-2):111-9. PubMed ID: 10799675 [TBL] [Abstract][Full Text] [Related]
13. LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia. Belayev L; Khoutorova L; Atkins K; Gordon WC; Alvarez-Builla J; Bazan NG Exp Neurol; 2008 Dec; 214(2):253-8. PubMed ID: 18793637 [TBL] [Abstract][Full Text] [Related]
14. Docosahexaenoic Acid therapy of experimental ischemic stroke. Belayev L; Khoutorova L; Atkins KD; Eady TN; Hong S; Lu Y; Obenaus A; Bazan NG Transl Stroke Res; 2011 Mar; 2(1):33-41. PubMed ID: 21423332 [TBL] [Abstract][Full Text] [Related]
15. Postischemic administration of basic fibroblast growth factor improves sensorimotor function and reduces infarct size following permanent focal cerebral ischemia in the rat. Li Q; Stephenson D Exp Neurol; 2002 Oct; 177(2):531-7. PubMed ID: 12429198 [TBL] [Abstract][Full Text] [Related]
16. Docosahexaenoic acid reduces cellular inflammatory response following permanent focal cerebral ischemia in rats. Chang CY; Kuan YH; Li JR; Chen WY; Ou YC; Pan HC; Liao SL; Raung SL; Chang CJ; Chen CJ J Nutr Biochem; 2013 Dec; 24(12):2127-37. PubMed ID: 24139673 [TBL] [Abstract][Full Text] [Related]
17. A glycine site antagonist ZD9379 reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion. Tatlisumak T; Takano K; Meiler MR; Fisher M Acta Neurochir Suppl; 2000; 76():331-3. PubMed ID: 11450037 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous hyperthermia and its mechanism in the intraluminal suture middle cerebral artery occlusion model of rats. Li F; Omae T; Fisher M Stroke; 1999 Nov; 30(11):2464-70; discussion 2470-1. PubMed ID: 10548685 [TBL] [Abstract][Full Text] [Related]
19. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720 [TBL] [Abstract][Full Text] [Related]